Assist
Where required, assists with the provision of analytical services, also ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Act.
Learn MoreThe Content of this website is for MATURE audiences only.
By continuing to view the website you are claiming that you are 18 years or older.
Call: +1 (246) 421-4141 | Email: clo@bmcla.bb
Where required, assists with the provision of analytical services, also ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Act.
Learn MoreDevelop policies, procedures and guidelines to establish the medicinal cannabis industry and to ensure that medicinal cannabis is available to patients in a safe and efficient manner.
Learn MoreIssues licences in relation to the handling of medicinal cannabis in accordance with the provisions of the Act, 2019, also provides for the distribution of educational materials etc.
Learn MoreRegulates the handling of medicinal cannabis, with the approval of the Barbados Medicinal Cannabis Licensing Board, establishes and maintains an electronic database.
Learn MoreA patient who needs to change his or her caregiver should notify his or her medical practitioner of the change, and give that medical practitioner such information as the medical practitioner may require in respect of the new caregiver.
Medicinal Cannabis is cannabis that is grown and sold pursuant to the Medicinal Cannabis Industry Act, 2019 that includes the seeds, immature plants as well as all parts of the plant, along with resin extracted from any part of the plant, every compound, manufacture, salt, derivative, mixture or preparation from cannabis; or cannabis concentrate; that is cultivated, processed, manufactured, distributed or sold under a licence from the BMCLA. As a medicine, it is prescribed and recommended by physicians to provide a therapeutic effect.
There are two major concerns regarding smoking medicinal cannabis.
Firstly, smoking is a particularly harmful way of taking medicinal cannabis, mainly because it poses comparable risks for bronchitis and lung cancer, as is the smoking of cigarettes. Smoking medicinal cannabis is not permitted by local or international Health authorities.
Secondly, approved medicines used in Barbados are produced under strict conditions to ensure efficacy and safety. It is important that medical doctors know that medicines have been tested and are standardized by dose and therapeutic response. This means doctors can monitor the effects of the drug and doses can be adjusted according to a patient’s needs.
It is understood that smoked cannabis will not be prescribed in Barbados because smoked plant products will not satisfy governmental requirements.
The BMCLA can suspend or revoke a license where:
the person issued the license is convicted of an offence under the Act;
the person issued with the license contravenes a term of condition of the license granted under the Act.
the Minister requires the suspension or revocation of the license in the interest of public health or public safety.
For more about the Barbados Medicinal Industry Act please click here
Prohibition against supply of medicinal cannabis A person shall not cultivate, supply, possess, or obtain medicinal cannabis for any of the purposes specified under the Act, unless that person is the holder of the relevant licenses issued pursuant to the Act. A person who cultivates, supplies, possesses, transports or obtains medicinal cannabis for any of the purposes specified under the Act without a relevant license is guilty of an offence and is liable on conviction on indictment, of a fine of 15 times the value of the medicinal cannabis cultivated, supplied, possessed, or obtained or to imprisonment for a term of 10 years, or to both.
11. How do you get medicinal cannabis?
A patient can only get access to medicinal cannabis as a prescription by a medical practitioner.
That prescription can only be filled by a pharmacist or authorised personnel in a pharmacy or therapeutic facility.
A pharmacist or authorised personnel in a pharmacy shall only dispense or supply medicinal cannabis on the submission by a patient or where applicable, a caregiver, of a prescription and a valid form of identification.
Upon dispensing medicinal cannabis to a patient (or, where applicable, a caregiver), a pharmacist or authorised personnel shall ensure that the label given in respect of the prescription has the information required by Pharmacy (Compounding and Dispensing of Drugs and Poisons) Regulations, 1986.
A pharmacist shall enter the information in a register kept by him/her and established for that purpose, in the prescribed manner.
A person who consumes medicinal cannabis without being authorised to use medicinal cannabis by a prescription or recommendation from a medical practitioner is guilty of an offence and is liable on conviction on indictment to a fine of $100 000 or to imprisonment for a term of 10 years or to both.
12. How is medicinal cannabis administered?
Medical cannabis can be administered by a variety of formulations which may include vapours, tinctures, oromucosal sprays, oral forms, transdermal patches, ointments and suppositories.
13. Will there be rigorous testing done to medicinal cannabis?
The BMCLA in conjunction with accredited testing laboratories will facilitate the testing of medicinal cannabis to ensure the products meet safety and efficacy requirements.
14. Will there be clear guidelines for prescribing medicinal cannabis for the use of patients or will doctors be left to experiment?
The BMCLA and its Board, are responsible for regulating the medicinal cannabis industry, through the formulation and implementation of appropriate policies, procedures and guidelines, as well as establishing the code of practice for practitioners in the industry. We work closely with the Ministry of Health and Wellness via its regulatory bodies such as the Barbados Drug Service to ensure safe and evidence-based treatment options for patients. Currently, there are five legally-approved medicinal cannabis drugs, placed on the National Drug Formulary. Patients can access these drugs under the provisions of Section 12 of the Drug Abuse (Prevention and Control) Act Cap 131.
15. Are there dose limitations?
In circumstances where a prescription by a medical practitioner requires repeated usage over a period of 3 months, a pharmacy or therapeutic facility shall not dispense to that patient more than 30-day supply of individual does at a time.